ADMA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
ADMA Biologics Inc is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows positive financial growth trends, hedge funds are buying significantly, and technical indicators suggest a neutral to slightly bullish sentiment. While there are no strong trading signals today, the stock's performance aligns with long-term growth potential.
The MACD is positive and expanding, indicating a bullish momentum. However, RSI is neutral at 51.623, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading above its pivot level (16.2), with resistance levels at 16.721 and 17.043, and support levels at 15.678 and 15.356.
Hedge funds are significantly increasing their positions, with a 719.51% increase in buying over the last quarter. The company has shown strong financial growth, with revenue, net income, and gross margin all increasing YoY. Additionally, the stock has an 80% chance of gaining 3.26% in the next month based on similar candlestick patterns.
No significant insider trading trends, bearish moving averages, and no recent congress trading data. The stock also lacks strong trading signals from AI Stock Picker or SwingMax today.
In Q3 2025, ADMA Biologics reported a 12% YoY increase in revenue to $134.22M, a 1.45% YoY increase in net income to $36.43M, and an EPS of 0.15 (unchanged YoY). Gross margin increased significantly by 13.16% YoY to 56.31%, indicating improved profitability.
No analyst rating or price target data provided. However, the financial growth trends and hedge fund activity suggest a positive outlook.
